PDFPrintEmailAdd to Personalized Information Packet

Advertising Litigation

Our firm has one of the nation’s premier advertising litigation practices. We represent many of the nation’s largest advertisers, including major pharmaceutical and consumer products companies, along with small and medium-sized retailers, software firms and other advertisers. We regularly provide our clients with advice regarding claim substantiation and advertising clearance.

Over the past 30 years, the firm has litigated and tried some of the most significant cases under the federal false advertising statute, the Lanham Act. U.S. News & World Report and Best LawyersBest Law Firms (2010-2014) ranked Kramer Levin’s Advertising Litigation practice in the national and New York top tiers for advertising law. From 2006 to 2014 Chambers USA and Legal 500 US have ranked our Advertising Litigation practice in its top tier, recognizing the leading role the firm plays in this area of litigation on a national level. Co-chairs Norman C. Simon and Harold P. Weinberger have consistently been recognized by Chambers USA and Legal 500 US as leading lawyers in Lanham Act litigation. Mr. Weinberger is also a Fellow of the American College of Trial Lawyers.

We have had extraordinary success litigating and trying advertising suits on behalf of our clients. We have prevailed in many highly publicized and significant cases, on behalf of both plaintiffs and defendants. Kramer Levin also regularly represents advertisers in challenges before the National Advertising Division (NAD) of the Better Business Bureau and the National Advertising Review Board (NARB).

Kramer Levin lawyers regularly author articles on advertising law and the Lanham Act in legal publications and speak on expert panels and symposiums on advertising law.

Chambers USA 2017 Recognizes Kramer Levin

Learn More

Advertising Litigation Report: Vol. 2, No. 2

The Advertising Litigation Report provides legal commentary on developments in Lanham Act cases, consumer fraud class actions, NAD challenges, data privacy and regulatory issues. Learn More